Articles by Greg Gille
French venture capital targets niche strategies
Niche-strategy vehicles are piquing corporate investors' appetite
PAI and Carlyle team up for $900m CST deal
First investment for both investors' latest vehicles
Have your say: UK Watch
With Q1 2014 already proving busy on the back of much improved market sentiment, where do you see the UK market heading in the coming months?
Last chance to vote: Delphi Nordic Private Equity Survey
Results to be revealed at the Nordic unquote" Private Equity Congress in May
LBO France cashes in on buoyant debt markets for Labeyrie and Exxelia
Record low coupon on Labeyrie bonds
LBO France's Labeyrie in €275m refinancing
Placement more than 15x oversubscribed
AA downplays flotation talks
Acromas confirms approaches, but no firm plan yet
Weekly round-up: Mood swings
Bullish mood at the EVCA Investor Forum; Ukrainian players trying to cope with the Crimea crisis; mid-market GPs wary of an IPO bubble in the UK... Here is your weekly round-up of industry analysis provided by unquote"
Strong second half boosts UK year-end activity figures
Read the latest unquote” Regional Mid-market Barometer, published in association with LDC
France struggles to play down SBO typecast
Early signs however hint at primary revival in 2014
Linkfluence raises further €3m from French VCs
Latest investment completes earlier €3.5m funding round
Emertec holds €50m first close for latest fund
Emertec 5 targets final close in the €55-60m region
XAnge et al. inject €6.75m into PrestaShop
Seventure and Serena Capital also take part in the round
Demeter and Emertec inject €1.8m into Ynsect
French biotech operates large-scale insect farm
Cinven, EQT target new geographies
European buyout houses Cinven and EQT have been looking further afield for healthcare investments, this week buying US-based CRO business Medpace and Australian radiology specialist I-Med, respectively.
Deal in Focus: Ardian backs €1.96bn Vinci Park buyout
France had not been home to a private equity transaction worth more than €1bn since the summer of 2011 – a dry spell broken in February, when Ardian entered exclusive talks with construction and concessions firm Vinci to back the buyout of its Vinci...
Boehringer Ingelheim leads early-stage round for Amal
Boehringer Ingelheim Venture Fund (BIVF) and High-Tech Gründerfonds have invested in a seed-funding round for Swiss biotech start-up Amal Therapeutics.
NVM Private Equity invests £3.5m in It’s All Good
NVM Private Equity has injected £3.5m into It’s All Good, a snack manufacturer specialising in tortilla chips.
Q&A: Michel Abouchalache, Quilvest & Partners
Q&A: Quilvest
Oxford Capital makes senior promotions
Martyn Holman, Oxford Capital
CEE: Activity picks up despite ongoing fundraising woes
An uptick in dealflow in the second half of last year has left local players hopeful for a more sustained recovery. Greg Gille reports
Charterhouse's Vivarte suspends debt payments
Vivarte, a French fashion group backed by Charterhouse Capital Partners, has suspended all payments on the €2.8bn debt load taken on as part of the 2007 buyout of the business.
3i's SLR bolts on US business
3i-backed environmental consultancy SLR Management has acquired US- and Canada-based HFP Acoustical Consultants.